Trial
NCT04495894
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Emory University
Collaborators
—
Condition
Non-small Cell Lung Cancer
Intervention
Preoperative Ketorolac
Why stopped
This study was terminated after interim analyses showed no benefits.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-04